How have ACST shares performed in 2024?

Acasti Pharma's stock was trading at C$0.58 at the start of the year. Since then, ACST stock has increased by 0.0% and is now trading at C$0.58. View the best growth stocks for 2024 here .

What other stocks do shareholders of Acasti Pharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Acasti Pharma investors own include Matinas BioPharma (MTNB) , Aurora Cannabis (ACB) , SCYNEXIS (SCYX) , Block (SQ) , Nokia Oyj (NOK) , Axsome Therapeutics (AXSM) , Blink Charging (BLNK) , Inovio Pharmaceuticals (INO) , Okta (OKTA) and Tesla (TSLA) .

How do I buy shares of Acasti Pharma?

Shares of ACST stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor , Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. Compare Top Brokerages Here .

CVE:ACST

Acasti Pharma (ACST) Stock Price, News & Analysis

→ REVEALED: Elon Musk’s Secret A.I. Facility? (From InvestorPlace) (Ad)

Free ACST Stock Alerts

C$0.58

+0.01 (+1.75%)

(As of 03/27/2023)

Compare

Today's Range: C$0.56
▼
C$0.58
50-Day Range: C$0.58
▼
C$0.58
52-Week Range: C$0.47
▼
C$1.66

Volume: 2,450 shs
Average Volume: 6,576 shs
Market Capitalization: C$25.87 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Acasti Pharma alerts:

Ad InvestorPlace

REVEALED: Elon Musk’s Secret A.I. Facility?

I recently shot this video outside what could be Elon Musk’s biggest secret. What’s happening inside these walls is so important that our government has declared it a matter of national security.

Click here to see the details because there’s a lot of money at stake.

About Acasti Pharma Stock (CVE:ACST)

Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.

ACST Stock Price History

30 days | 90 days | 365 days | Advanced Chart

ACST Stock News Headlines

April 6, 2024 | finance.yahoo.com

Acasti Pharma Inc. (ACST)

March 14, 2024 | edition.cnn.com

Acasti Pharma Inc. Class A

April 16, 2024 | InvestorPlace (Ad)

REVEALED: Elon Musk’s Secret A.I. Facility?

I recently shot this video outside what could be Elon Musk’s biggest secret. What’s happening inside these walls is so important that our government has declared it a matter of national security.

February 25, 2024 | msn.com

Acasti Pharma (ACST) Price Target Increased by 200.00% to 6.12

February 12, 2024 | finance.yahoo.com

Acasti Announces Third Fiscal Quarter 2024 Financial Results and Business Highlights

December 25, 2023 | finance.yahoo.com

Will Acasti Pharma (NASDAQ:ACST) Spend Its Cash Wisely?

November 14, 2023 | investing.com

Acasti Pharma (ACST) Earnings Dates & Reports

November 11, 2023 | morningstar.com

Acasti Pharma Inc Class A ACST

April 16, 2024 | InvestorPlace (Ad)

REVEALED: Elon Musk’s Secret A.I. Facility?

I recently shot this video outside what could be Elon Musk’s biggest secret. What’s happening inside these walls is so important that our government has declared it a matter of national security.

September 26, 2023 | benzinga.com

Why Acasti Pharma (ACST) Stock Is Exploding Higher

September 6, 2023 | technews.tmcnet.com

Acasti to Participate in the H.C. Wainwright Global Investment Conference

August 11, 2023 | finanznachrichten.de

Acasti Pharma, Inc.: Acasti Announces First Quarter 2024 Financial Results and Business Highlights

June 23, 2023 | finanznachrichten.de

Acasti Pharma Inc.: Acasti Pharma Reports Fiscal Year 2023 Operational Results

June 23, 2023 | finance.yahoo.com

Acasti Pharma Reports Fiscal Year 2023 Operational Results

June 22, 2023 | finance.yahoo.com

Acasti Announces Appointment of New Scientific Advisory Board Members

June 20, 2023 | sg.finance.yahoo.com

ACST - Acasti Pharma Inc.

April 7, 2023 | theglobeandmail.com

Closing Bell: Acasti Pharma Inc up on Monday (ACST)

April 4, 2023 | seekingalpha.com

Acasti Pharma announces CEO transition

March 16, 2023 | morningstar.com

Acasti Pharma Inc. Centralizes Marketplace for Shares on the Nasdaq with Voluntary Delisting from TSX Venture Exchange | Morningstar

March 8, 2023 | finance.yahoo.com

Acasti Pharma to Participate in Oppenheimer 33rd Annual Healthcare Conference

March 4, 2023 | finance.yahoo.com

We're Hopeful That Acasti Pharma (CVE:ACST) Will Use Its Cash Wisely

March 1, 2023 | finance.yahoo.com

Acasti Pharma Recognizes Rare Disease Day

February 28, 2023 | msn.com

Has Acasti Pharma (ACST) Outpaced Other Medical Stocks This Year?

January 13, 2023 | benzinga.com

Acasti Pharma to Present at Sidoti Virtual Investor Conference on January 18

November 15, 2022 | seekingalpha.com

Acasti Pharma Inc. (ACST) Q2 2023 Earnings Call Transcript

November 9, 2022 | it.tmcnet.com

Acasti Pharma to Present at Q4 Investor Summit

November 8, 2022 | tmcnet.com

Acasti Pharma to Report Second Quarter 2023 Financial

See More Headlines

Receive ACST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Acasti Pharma and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: CVE
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: CVE:ACST
Previous Symbol: CVE:APO
CUSIP: N/A
CIK: N/A
Web: www.acastipharma.com
Phone: +1-450-6864555
Fax: N/A
Employees: 32
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): C($0.54)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: C$-17,250,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -16.60%
Return on Assets: -8.25%

Debt

Debt-to-Equity Ratio: 0.52
Current Ratio: 9.74
Quick Ratio: 9.41

Sales & Book Value

Annual Sales: C$115,000.00
Price / Sales: 224.99
Cash Flow: C$0.93 per share
Price / Cash Flow: 0.63
Book Value: C$2.17 per share
Price / Book: 0.27

Miscellaneous

Outstanding Shares: 44,610,000
Free Float: N/A
Market Cap: C$25.87 million
Optionable: Not Optionable
Beta: 1.22

These 7 Stocks Will Be Magnificent in 2024

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

Ms. Janelle D'Alvise (Age 68)
Pres, CEO, Corp. Sec. & Director
Comp: $620.16k
Dr. Pierre Lemieux M.D. (Age 58)
Ph.D., Co-Founder, COO & Chief Scientific Officer
Comp: $398.75k
Mr. Brian D. Ford CPA (Age 64)
CA, Chief Financial Officer
Comp: $340.84k
Dr. George Kottayil (Age 60)
Chief Operating Officer of US
Comp: $160.16k
Mr. Prashant Kohli
Chief Commercial Officer
Dr. Yves Lachance Ph.D.
VP of Quality & Compliance
Ms. Christine Pelletier
Sr. Director of HR

Key Competitors

View All Competitors

ACST Stock Analysis - Frequently Asked Questions

How have ACST shares performed in 2024?: Acasti Pharma's stock was trading at C$0.58 at the start of the year. Since then, ACST stock has increased by 0.0% and is now trading at C$0.58.
View the best growth stocks for 2024 here.
What other stocks do shareholders of Acasti Pharma own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Acasti Pharma investors own include Matinas BioPharma (MTNB), Aurora Cannabis (ACB), SCYNEXIS (SCYX), Block (SQ), Nokia Oyj (NOK), Axsome Therapeutics (AXSM), Blink Charging (BLNK), Inovio Pharmaceuticals (INO), Okta (OKTA) and Tesla (TSLA).
How do I buy shares of Acasti Pharma?: Shares of ACST stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (CVE:ACST) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Acasti Pharma (ACST) Stock Price, News & Analysis

About Acasti Pharma Stock (CVE:ACST)

ACST Stock Price History

ACST Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

ACST Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info